Filing Details
- Accession Number:
- 0001127602-20-001110
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-06 16:06:45
- Reporting Period:
- 2020-01-02
- Accepted Time:
- 2020-01-06 16:06:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
859737 | Hologic Inc | HOLX | X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844) | 042902449 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1314036 | Marie Karleen Oberton | 250 Campus Drive Marlborough MA 01752 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-01-02 | 10,375 | $21.45 | 39,331 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-01-02 | 5,973 | $23.82 | 45,304 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-01-02 | 10,375 | $51.66 | 34,929 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-01-02 | 5,973 | $51.85 | 28,956 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2020-01-02 | 10,375 | $0.00 | 10,375 | $21.45 |
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2020-01-02 | 5,973 | $0.00 | 5,973 | $23.82 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2014-11-18 | 2020-11-18 | No | 4 | M | Direct |
0 | 2015-05-26 | 2021-05-26 | No | 4 | M | Direct |
Footnotes
- Transaction pursuant to an existing 10b5-1 trading plan.
- Includes 4,401 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan.
- The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $51.55 to $51.785 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $51.535 to $52.13 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- This option to purchase common stock becomes exercisable in equal installments on each of the first four anniversaries of the grant date, November 18, 2013.
- This option to purchase common stock becomes exercisable in equal installments on each of the first four anniversaries of the grant date, May 26, 2014.